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Risiini kuuluu Kemiallisen aseen kieltosopimuksen (CWC) listan 1 kemikaaleihin. Sille ei 
ole tunnettua vastalääkettä ja se on myös terrorismiriski myrkyllisyytensä vuoksi. 
Mahdollisen väärinkäytön uhan vuoksi on tärkeää, että risiinille on tarkka 
havainnointimenetelmä. Tässä opinnäytetyössä optimoitiin ja validoitiin entsymaattinen 
risiinin määritysmenetelmä, kerrosmainen entsyymivälitteinen immunosorbenttimääritys 
(kerros ELISA) Kemiallisen aseen kieltosopimuksen instituutille (VERIFIN). 
 
Kerros ELISA -menetelmän optimointi keskittyi vasta-aineiden biotinylointiin, 
puskuriliuoksiin, vasta-ainekonsentraatioihin ja entsyymikonjugaatin konsentraatioon. 
Vasta-aine- ja entsyymikonjugaatin konsentraatiot määritettiin titraamalla ja parhaat 
konsentraatiot valittiin signaali-kohinasuhteen perusteella. Validointi keskittyi nollarajan 
(LOB), toteamisrajan (LOD), sisäisen analyysin ja analyysien väliseen tarkkuuteen, 
saantoon ja spesifisyyteen. LOB:n, LOD:n ja analyysin tarkkuuden tulokset määritettiin 
useasta ELISA-tuloksesta. Saantokokeissa testattiin ELISA-menetelmää kolmella eri 
näytematriisilla: maidolla, punaviinillä ja vehnäjauhoilla. Menetelmän spesifisyys testattiin 
käyttämällä kahta risiinin kaltaista proteiinia, agglutiniinia ja abriinia.  
 
Menetelmän optimointi onnistui ja menetelmällä pystyttiin havaitsemaan vaivattomasti 
risiinikonsentraatiot 0,03 % BSA ja 0,1 % TritonX PBS liuoksessa 7,6 pg/ml asti. Vasta-
aineiden optimoidut konsentraatiot olivat päällystykseen 2,5 µg/ml ja havainnointiin 0,8 
µg/ml. Entsyymikonjugaatille optimoitiin 1 ng/ml pitoisuus. LOB oli 2,4 pg/ml ja LOD oli 2,9 
pg/ml. Sisäisen analyysin tarkkuus vaihteli 3,9 % ja 105 % välillä. Analyysien välinen 
tarkkuus vaihteli 14 % ja 35 % välillä. Näytematriisit haittasivat risiini ELISAa, ja näiden 
osalta saannot jäivät alhaisiksi. Risiini ELISA ristireagoi agglutiniinin kanssa, kun 
agglutiniinia oli näytteessä 25 pg/ml. Abriini ei sitoutunut käytettyihin risiinivasta-aineisiin.  
 
Kerros ELISA risiinille toimi hyvin, kun käytössä oli optimoitu näyte matriisi, 0,03 % BSA ja 
0,1 % TritonX PBS:sä, mutta käytettäessä kolmea testattua matriisia oli niillä huomattava 
vaikutus analyysiin ja risiinin havainnointiin. Validointitulokset osoittavat, että 
menetelmässä on vielä useita osa-alueita joita tulisi kehittää.  
Avainsanat Risiini, kerrosmainen entsyymivälitteinen 
immunosorbenttimääritys, kerros ELISA, biotiini, biotinylaatio, 
validointi, immunoanalyysin optimointi, vasta-aine, LOB, LOD, 
saanto, ristireaktio 
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Ricin is listed in the Chemical Weapons Convention (CWC) as a schedule 1 toxic chemical 
with no known antidote and threat of terrorism due to its toxic nature. Because of the 
potential misuse, a method for precise detection of ricin is crucial. In this study enzymatic 
ricin detection method, Sandwich Enzyme-Linked Immunosorbent Assay (sandwich 
ELISA), was optimized and validated for the Finnish Institute for Verification of the 
Chemical Weapons Convention (VERIFIN). 
 
Sandwich ELISA method optimization is focused on antibody biotinylation, multiple buffer 
solutions, antibody concentrations and conjugate enzyme concentration. Antibody and 
conjugate enzyme concentrations were determined using titration and concentrations 
where ideal signal-to-noise ratio were chosen. Validation focused on limit of blank (LOB), 
limit of detection (LOD), intra- and inter-assay precision, recovery and specificity. LOB, 
LOD and assay precisions were determined from multiple ELISA results. Recovery of the 
ELISA method was tested using three matrices: milk, red wine and wheat flour. Specificity 
was tested using two ricin like proteins agglutinin and abrin. 
 
Method optimization was successful detecting ricin in 0.03 % BSA 0.1 % TritonX in PBS 
solution comfortably down to 7.6 pg/ml. Optimized concentrations for antibodies were for 
coating 2.5 µg/ml, detection 0.8 µg/ml and conjugate enzyme was optimized to 1 ng/ml. 
LOB was 2.4 pg/ml and LOD was 2.9 pg/ml. Intra-assay precision was lowest at 3.9 % and 
highest at 105 %, inter-assay precision low was 14 % and a high of 35 %. Sample matrices 
disturbed the ricin ELISA determination and recovery from three matrices were low. No 
cross reactivity for abrin was found. However, agglutinin from 25 ng/ml onwards was 
detected. 
 
Sandwich ELISA for ricin works well when using optimized sample matrix, 0.03 % BSA   
0.1 % TritonX in PBS, but the other three matrices had substantial effect on the assay and 
ricin detection. Validation results suggest that the assay has still a lot to be improve upon.  
Keywords Ricin, sandwich enzyme-linked immunosorbent assay, 
sandwich ELISA, biotin, biotinylation, validation, 
immunoassay optimization, antibody, LOB, LOD, recovery, 
cross reactivity 
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1 Introduction 
This study was conducted at the Finnish Institute for Verification of the Chemical 
Weapons Convention (VERIFIN), which is an institute at the Department of Chemistry at 
the University of Helsinki. VERIFIN was founded in 1994 as a continuance for the 1973 
Chemical Weapons research project (CW). Fundamental missions of VERIFIN are to 
develop analytical methods for Chemical Warfare Agents (CWA), aiding Organisation for 
Prohibition of Chemical Weapons (OPCW) and United Nations (UN) and training 
chemists from developing nations. VERIFIN also functions as the National Authority of 
Finland for the Chemical Weapons Convention (CWC), performs tasks specified by the 
Ministry for the Foreign Affairs of Finland, conducts research and teaches post-
graduates. Working as the designated laboratory for OPCW, VERIFIN can receive 
authentic environmental and biomedical samples. [1] 
Objective for this study was to optimize enzymatic method of ricin detection for the 
institute. The study concentrated on method optimization and validation for sandwich 
ELISA (Enzyme-linked immunosorbent assay). Since there are no commercial kits 
available for ricin ELISA detection the purpose was to develop a method to obtain reliable 
results in ricin determination. Purpose was also to provide VERIFIN with detailed working 
instructions for the use of sandwich ELISA. This study was lightly associated within 
EuroBioTox project, a European project focusing on assessment and improvement of 
toxin detection methods. EuroBioTox is aiming for a network of European laboratories 
with universal way of handling biotoxin incidents. [2] 
Ricinus communis plant is universally used source for castor oil, a raw material in several 
products such as cosmetics, lubricants and pharmaceuticals. Ricin is very accessible 
and easily obtained. Its high toxicity makes it a prospective agent for bioterrorism. 
Previously ricin has been used for bioterrorism in the case of Georgi Markov and threat 
letters containing ricin sent to the U.S. Senate, White House and President Obama. Ricin 
is listed as a prohibited substance in the CWC and the Biological Weapons Convention 
(BWC). Because of potential misuse of ricin, a method for rapid and precise detection of 
ricin is essential. [3] 
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2 Chemical Weapons Convention 
The goal set out by the Convention is to eliminate all weapons of mass destruction. The 
Convention prohibits all member states, so called state parties (currently 192), of 
development, production, stockpiling, transferring or using chemical weapons. States 
parties are obliged to execute the prohibition within their jurisdiction. Within the CWC all 
state parties have agreed to destroy all chemical weapons they may possess and 
weapons left abandoned in their territory. State Parties are obliged to create a verification 
administrative system for some toxic chemicals and their precursors to ensure that those 
chemicals are used in ways that are not prohibited. [4] 
Ricin belongs to the Schedule 1 toxic chemicals of CWC. Schedule 1 chemicals have 
been used, developed, produced or stockpiled as a chemical weapon. A chemical can 
be listed under the Schedule 1 when it possesses lethal toxicity or is incapacitating, has 
a structure similar to other listed chemicals, can be used as a precursor for listed 
chemicals and has little or no use for purposes not prohibited under the Convention. [4]  
Even ricin was found not effective enough for military use, as it has been used for multiple 
attacks and incidents. There have been 12 known incidents involving ricin, including 
Minnesota militia members intention to kill government officials in 1994 and Kurdish 
Sunni Islamists testing ricin on animals for use in terrorist acts in the United Kingdom [5, 
158; 6, 282]. Presumably the most well-known ricin incident is the murder of Bulgarian 
writer Georgi Markov. He had defected to the West and was working for the British 
Broadcasting Corporation (BBC) World Service in London. September 7th in 1978 he 
was waiting for bus near Waterloo Bridge when he was stabbed in the calf with an 
umbrella containing a platinum pellet loaded with ricin. [6, 283; 7, 141] Markov developed 
a high fever and was submitted to hospital where he died on the 11th of September 1978 
[8]. Cause of death was a complete block of the cardiac conductive tissue [6, 283]. 
Postmortem revealed pulmonary edema, hemorrhages on heart, intestines, and lymph 
nodes [8]. Two weeks prior Bulgarian exile Vladimir Kostov was attacked in Paris metro 
using an almost identical method to the Markov case, but the pellet did not penetrate 
deeply and Kostov survived [6, 283]. 
Because of these incidents in the past, it is possible that ricin will be used again and 
therefore research of ricin detection and determination is essential. 
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3 Biological Weapons 
Biological weapons, as BWC Article 1 states, refer to the means of spreading any 
biological agents and toxins. These means are munitions, bombs, aircraft spray tanks 
and other devices. [5, 3; 9] 
Biological weapons have been used throughout the history of warfare. Polluting wells 
using animal carcasses and disposal of plague victim corpses inside enemy city walls 
(siege of Caffa in 1346). More recent cases of biological weapons use include the 
smallpox infected blankets that British army gave to the American Indian tribe in 1763. 
[5, 3‒5] 
The first agreement of prohibition of chemical and biological weapons was made on 1675 
in Strasbourg. France and Germany agreed not to use poison bullets. [5] After 200 years 
a prohibition of “poisons and poisoned weapons” was agreed at Brussels Conference in 
1874. In 1899 European delegates agreed on not using projectiles for spreading of 
“asphyxiating or deleterious gases”. Even though these prior agreements were signed in 
1907, it did not prevent use of chemical weapons by both sides in World War I, nor use 
of biological agents. [5, 3‒5] 
In modern war biological weapons have been verifiably used in two cases: Japan in 
Manchuria from 1934 to 1945 and Germany in World War I. In Manchuria the Japanese 
army developed a biological program and intentionally spread epidemics by 
contaminating food and water and using plague-infected fleas. During World War I 
Germans were trying to infect pack animals with anthrax and glanders. [5, 4‒5] 
From World War I and onwards multiple countries including France, the United Kingdom, 
the United States of America and Soviet Union have been developing different biological 
weapons [6]. Early on scientists realized that bombs with bacteria were close to 
impossible to produce, because of the heat when detonating. Use of virulent agents and 
toxins, especially botulinum and ricin, were researched further. Botulinum was difficult to 
produce in large quantities and ricin was found to be not effective enough for military 
use. [5, 14‒15]  
After the Cold War, a plan for BWC came to life. BWC wanted similar protocols and 
methods as CWC had achieved. USA, Russia and China expressed their resistance in 
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the beginning for multiple reasons. In the end an agreement was found. [5, 148] Today 
BWC has 175 state-parties [10]. 
4 Ribosome Inactivating Protein (RIP) 
4.1 Ricin 
Ricin, highly toxic plant toxin, originates from seeds of castor bean plant, Ricinus 
communis, the source of castor oil (Figure 1) [11; 12]. Castor oil is used in multiple 
applications, such as lubricants, cosmetics and detergents [11]. Origination of the plant 
is most likely from Africa and now it grows wild and as an ornament in tropical and 
subtropical regions [13]. Weight of the castor bean consist of approximately 1–5% of ricin 
protein [14]. 
 
Figure 1.  Ricinus communis plant in bloom (a) and seeds of R. communis cultivars (b) from left to right: R. 
c. zanzibariensis, R. c. zanzibariensis, R. c. green giant, R. c. zanzibariensis, R. c. carmencita, R. c. india, 
R. c. tanzania. [13] 
The water-soluble protein was originally identified in 1888 by Stillmark [3; 6, 1; 13] and it 
consist of two polypeptide chains, making it an AB toxin. Chains A and B are linked 
together with disulfide bond (Figure 2). Ricin belongs to a large gene family that also 
encodes seven full-length ricin or ricin like proteins and several shorter genes with 
unknown properties. These seven full-length proteins have similar protein synthesis 
inhibition properties as ricin. [3] Ricin is type 2 ribosome-inactivating proteins (RIP-II) in 
size approximately 64 kDa. [12] B-chain has lectin activity and binds to different 
oligosaccharide residues located on the cell surface. After entering the cell, ricin protein 
uses the Golgi network for travel in endoplasmic reticulum where the two chains are 
reduced. After reduction into two chains the catalytically active A-chain, acting as RNA 
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N-glycosidase, gets transported to cytosol where it binds to ribosomal stalk of the 
ribosome and removes one adenine from GAGA tetraloop of 28S rRNA [3; 12; 13]. 
Removal of the adenine prevents binding of elongation factor 2 inhibiting protein 
biosynthesis and leads to cell death. 
 
Figure 2. Crystal structure of ricin bound with dinucleotide ApG (PDB ID: 3RTJ). Two chains shown with 
different colours, A chain as white and B chain as blue. [15] 
Ricin toxicity when ingested is estimated to be 1‒20 mg/kg body weight and inhaled or 
injected 1‒10 µg/kg body weight. [3; 12] After ingestion symptoms of ricin intoxication 
arise from 4 to 6 hours but it may take as long as 10 hours. The first symptoms are 
universal and can consist of abdominal pain, nausea and vomiting. These symptoms are 
usually followed by cramps, diarrhea, fever, sore throat, dehydration, dilation of pupils, 
headache, low blood pressure, heartburn, internal bleeding of digestive system and 
failure of the kidneys, liver and spleen. Death can follow after three or more days when 
the vascular system fails. There are no known antidotes or vaccines available for ricin 
intoxication and treatment for the intoxication is based on supporting the body´s natural 
response. [16] 
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Due to previous military and bioterrorism use ricin is a prohibited substance under the 
CWC and the BWC. OPCW rigorously regulates and controls possession or purification 
of the protein. Despite its destructive uses the catalytic A-chain of ricin has been one of 
the first examples of a toxin conjoined to monoclonal antibodies (mAb) against cell 
surface proteins. It has been also tested experimentally for the treatment of various 
cancers. [17] 
Characterization is hindered by another protein present in seeds called R. communis 
agglutinin, RCA120. Another problem with detection is two existing ricin isoforms D and 
E (Figure 3). [3] 
 
Figure 3. Amino acid sequence homologies between ricin isoforms D and E, agglutinin and abrin [18].  
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4.2 Agglutinin, RCA120 
Agglutinin, also known as RCA120 is a heterotetrameric 120 kDa protein consisting of 
two heterodimers similar to that of ricin connected via disulfide bond. Ricin and agglutinin 
share a very similar sequence, 93 % in A chain and 84% in B chain (Figure 3). 
Nevertheless, ricin is 300-fold more toxic than RCA120. [3] 
4.3 Abrin 
Abrin is a toxic protein in the seeds of Abrus precatorius, also known as rosary peas, 
jequirity bean, and crab's eye. Molecular weight of abrin is approximately 65 kDa and it 
has two subunits A and B similar to ricin. Abrin is RIP-II protein and has high amino acid 
sequence homology with ricin (Figure 3). Inhaled toxicity for humans is estimated at 0.1–
1 µg/kg. First symptoms are vomiting and diarrhea following bloody diarrhea and black 
stools. [19] 
4.4 Methods for Identification and Detection of Ricin 
There are several methods for ricin identification and detection, such as immunological, 
spectrometric, functional and molecular approaches, but no universal approach has 
been agreed on. [3] 
Methods for determination of protein composition, size and purity are sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and capillary gel 
electrophoresis (CGE) [3]. Both methods are based on the molecular size [20]. 
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-
TOF/MS) and liquid chromatography-electrospray ionization mass spectrometry (LC-
ESI/MS) are both used for tryptic fingerprinting and sequencing. LC-ESI/MS is also 
utilized for molecular weight determination and MALDI-TOF/MS for analysing trace 
contaminants. [3] Both methods use mass spectrometry for identification, but the 
ionization technique differentiates. Electrical energy is exploited in ESI, where ions in the 
liquid are dispersed as minuscule charged droplets into gaseous phase [21]. MALDI-
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TOF applies a laser that heats the sample matrix, which is vaporized and various 
charged ions are released [22]. 
Enzyme-linked immunosorbent assay (ELISA) is used for detection of ricin. Because in 
this method ricin and antibodies with other reagents create a colour reaction, it can be 
used with spectrometric methods to measure ricin concentration. For faster screening 
lateral-flow assays (LFA) are used and can measure ricin up to 1-50 ng/ml [3; 13]. Ricin 
antibody reaction can also be applied to Western Blot. [3] In Western blot separation of 
proteins is based on molecular weight. Separated proteins are transferred to a 
membrane and membrane incubated with specific antibodies. [23]  
Cytotoxicity assay measures functional activity. It is based on cell viability and death 
when ricin is introduced to the cell culture plate. Functional activity measurements 
indicate presence of intact ricin molecule. Ricin molecule needs to be intact with its both 
chains to be toxic. [3] 
5 Enzyme-Linked Immunosorbent Assay, ELISA 
Enzyme-linked immunosorbent assays are plate based assays used for protein, 
antibody, peptide and hormone quantification and detection. It is assay with multiple 
perks as it needs lesser volumes of reagents, adapts to different detection systems and 
needed reagents and equipment are accessible for most laboratories. In ELISA, antigen 
can bind to the assay plate or be captured by antibody immobilized on the plate. [24] 
Immobilization and binding of reagents make it easy to plan and perform and non-
specifically bound material can be easily washed away, making it an excellent assay for 
specific analyte detection and quantification. [25] In ELISA method, antibodies detect the 
antigen directly with labelled primary antibody or indirectly with labelled secondary 
antibody. [24] Measurable detection, usually a colour, is achieved with conjugate and 
substrate in incubation and measured using different methods. The most essential 
component of the assay is a specific interaction between the antibody and antigen. [25] 
Common ELISA formats are direct and indirect. Both capture and detection can be direct 
or indirect and capture and detection formats can be mixed together (Figure 4). When 
antigen is immobilized to microtiter plate, it is called a direct capture. For indirect capture 
microtiter plate is first coated with specific antibody and antigen that binds to the 
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antibody. In direct detection primary antibody with conjugated reporter binds to antigen 
and substrate that reacts with conjugated reporter is added for detection. When primary 
antibody attaches to antigen which then will be recognised by secondary antibody with 
attached conjugate reporter, is called indirect detection. In indirect detection substrate is 
added, but when compared to direct detection there are more conjugate reporters for 
one antibody and the signal is stronger. [25] 
 
Figure 4. Mixture of direct and indirect capture and detection using horseradish peroxidase (HRP). 
10 
  
5.1 Sandwich ELISA 
In sandwich ELISA, antigen is bound between two antibodies, the capture antibody and 
the detection antibody [24]. Antibodies used for the assay can be either monoclonal or 
polyclonal. Monoclonal recognize single epitope, thus making quantification easier and 
it is usually used as a detection antibody. Polyclonal binds considerable amounts of 
antigen and is often used as a capture antibody. Antigens used for sandwich ELISA must 
contain at least two sites able to bind antibodies. [26] Sandwich method is more sensitive 
because of indirect capture and indirect detection. In sandwich ELISA the capture 
antibody is immobilized to microtiter plate. Antigen binds to the capture antibody and 
labelled detection antibody binds to antigen. Conjugate binds to label used in detection 
antibody and reacts with substrate forming measurable product (Figure 5). [25] Multiple 
sandwich ELISA formats have been developed for ricin detection [24]. Sandwich ELISA 
can be challenging to optimize [26]. 
 
Figure 5. Sandwich ELISA with biotinylated detection antibody and streptavidin-horse radish peroxidase 
(SA-HRP) conjugate [24] 
5.2 Antibodies 
When infectious pathogens or toxins are found, mammal B cells secrete and produce 
antibodies. Antibodies bind to the antigen and with other immune system proteins they 
inactivate foreign antigens. B cells produce specific antibodies to match antigens 
epitopes. Single antigen can contain multiple different epitopes, but B cell can only 
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produce one kind of antibody matching only one epitope. Because of this B cells 
differentiate to produce different antibodies against different epitopes. [27, 119] 
There are different types of antibodies, polyclonal (pAb), monoclonal and recombinant 
antibodies. These antibodies differentiate from each other in production. Polyclonal 
antibodies are produced by multiple different B cells against same antigen. Polyclonal 
antibodies bind to different epitopes on the antigen. Monoclonal antibodies are produced 
using B cells cloned from one B cell. All produced antibodies are then similar and bind 
to only one epitope of certain antigen. Monoclonal antibodies are more specific than 
polyclonal. Recombinant antibodies are combination of mouse mAbs with human 
segments. These are used clinically for multiple purposes. [27, 119–120] 
6 Biotin 
Biotin is also known as vitamin B7, vitamin H and coenzyme R. It is nontoxic and water-
soluble, important coenzyme involved in carbon dioxide transfer in carboxylase 
reactions. [28; 29; 30] Numerous plant and animal tissues such as liver, brains, yolks 
and corn kernels are rich with biotin [30]. Because of biotins small size of 244 Da it does 
not usually alter proteins biological activities [29]. Valeric acid chain of biotin molecule 
(Figure 6) works as a spot for adding different reactive groups that promote biotin 
labelling to other molecules [30]. Biotin binds with high affinity to streptavidin and avidin 
making it an attractive component for molecular tests and immunoassays [28; 29].  
 
Figure 6. Biotin molecule structure [31]. 
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6.1 Biotinylation 
The process attaching biotin with chemical or enzymatic methods to antibodies, proteins 
or other macromolecules is called biotinylation [29; 31]. Chemical methods are more 
superior compared to enzymatic methods and can be performed in vivo and in vitro. For 
this reason, when biotinylation is mentioned, it refers to the chemical methods. [31] 
Reagents available for biotinylation have all similar features. Reagents can be targeted 
for certain functional groups as sulfhydryls, primary amines, carbohydrates and 
carboxyls. Targeting biotin to right functional group prevents target molecule inactivation. 
Moieties are attached to valeric acid chain with a structure called spacer arm. The length 
of the spacer arm increases (long spacer arm) or decreases (short spacer arm) 
depending on availability of biotin for avidin binding. [31] 
Besides spacer arm length there are other factors affecting biotinylation. Solubility of the 
biotinylation reagent affects ability to label targets. Reagent solubility is hinged on 
reactive moiety (part of functional group in molecule), spacer arm or a combination. 
Biotinylation reagents cleavability/reversibility affects the ability to purify labelled proteins 
by cleaving biotin or reversing biotin-avidin complex. Lastly, and perhaps the most 
substantial factor, is targeting the functional groups. To reduce potential interference of 
biotinylation reagent conjugating to amino acids that regulate normal protein function, 
there are many accessible moieties. Selection of right moiety is crucial for successful 
biotinylation. In this study biotin was targeted for primary amines (Figure 7), the most 
commonly targeted functional group. N-hydroxysuccinimide (NHS) forms bonds with 
primary amines and do not carry a charge. Therefore NHS-esters are usually altered to 
be water-soluble by sulfonating N-hydroxysuccinimide ring to form sulfo-NHS. [31] 
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Figure 7. Biotin used on the thesis analysis [29].  
6.2 Biotin Quantitation 
Knowing the amount of biotin bound to a sample can be useful and aid optimization of 
assay system. Common method for measuring labelled biotin amounts is 4'-
hydroxyazobenzene-2-carboxylic acid dye also known as HABA. In this method HABA 
is covalently bound to avidin when there is no biotin around. When biotin is available it 
replaces HABA. This is because its association constant for biotin-avidin is higher than 
HABA-avidin. Both mixes display absorbance at wavelength 500 nm, but higher 
absorbance is available when HABA is bound to avidin than when biotin replaces it. 
When measured absorbances are deducted the amount of biotin bound in the sample 
can be calculated. New methods for quantitation use the same principle as above, but 
use more sensitive fluorescent reporters. [31] 
7 Immunoassay Optimization 
Key to precise ELISA assay is in three steps: method development, optimization and 
validation. Method development starts with deciding of antibodies, antigens, enzymes 
and method of detection to use. In optimization, all these elements get tested and titrated 
to achieve ideal assay performance. Part of optimization is also making the most 
effective compromises between convenience and analytical capability. Lastly, validation 
measures developed and optimized method.  [32, 381]  
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ELISA assay optimization will need multiple experiments to achieve the best results. The 
primary target for ELISA is to identify antigen, have a most favorable environment for 
binding affinities and assay kinetics and grant consistent results with high sensitivity and 
specificity. To meet these requirements, many factors must be balanced. [32, 390]  
Every different ELISA method has its unique reagent formulation. Commercial reagents 
can shorten development time, but may also lead to possible problems because the 
reagents are not optimized. Thus, every assay reagent must be determined empirically 
for optimal concentrations. Popular reagent concentration determination is checkerboard 
titration, also known as a two-dimensional serial dilution. It is often used for achieving 
optimized dilutions. In this titration of two components concentration is varied, making it 
a pattern resembling its name. [32, 391] 
The signal-to-noise ratio is the ratio of signal of sample compared to level of noise. Noise 
is the signal when no analyte is in the sample. When the signal-to-noise ratio enhances, 
the assay will be more effective detecting small quantities of antigen. To enhance the 
signal-to-noise ratio you can either reduce noise or increase signal. [32, 391] 
7.1 Buffers 
Buffers are the foundation of ELISA. Factors to be considered in buffer formulation are 
buffer system, pH, ionic strength, salt, detergent, blocking agents, proteins, 
preservatives, and other additives. Detergents in buffers can reduce nonspecific binding, 
but all detergents do not go well with all antigens. Use of a detergent, high salt and 
certain pH range may be inhibited by antigens conformational epitope. Buffers can be 
used to stabilize antigen–antibody complex and can result in better surface 
complementarity. This is important to the accessibility mobility and antigenicity of an 
antigen. Antigens flexibility allows its epitope to assume more easily suitable 
configuration in the antibody-binding site. [32, 391] 
7.1.1 Blocking Buffer  
Blocking unoccupied sites is essential for preventing nonspecific binding. Antibody 
antigen pairs can require different blocking buffers because of their different 
characteristics. Used blocker depends on the antigen and on the enzyme conjugate. Well 
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selected and tested blocking buffer can increase specificity and sensitivity. [32, 388] Best 
sign for right blocking buffer choice is signal-to-noise ratio. Excessive blocking can 
obscure antibody-antigen interactions resulting in lower signal-to-noise ratio. [32, 391] 
For blocking buffer optimization, different buffer solutions and concentrations are 
prepared to experiment with [33]. 
7.2 Capture Antibody and Detection Antibody Concentration 
Optimum antibody concentration is critical. It improves assay performance and may save 
funds. Optimizing the concentrations is the key part of the assays sensitivity, right 
amounts will yield best results detecting very low concentrations of antigen. [32, 387] In 
optimization multiple different dilutions of capture and detection antibody are made and 
tested for the best result. Ideal results are with strong signal and low background [33].  
7.3 Standard Diluent and Sample Volume 
Standard diluent should be as close as possible to sample matrix if not the same matrix.  
Range for standard curve and linearity of dilution should be dynamic. If these are not met 
diluent should be a changed. [33]  
Sample volume should be defined by minimal interference and matrix effect. Reaction of 
antibody–antigen develops at the solid–liquid interface. This makes it difficult to 
determine exact reaction volume. Larger volume can increase assay sensitivity, but it 
might lower linearity. [32, 391] 
7.4 Enzyme Conjugate Concentration 
Most commonly used enzyme conjugate is horse radish peroxidase (HRP). It produces 
coloured, luminescent and fluorometric derivative when incubated with a substrate. It 
generates strong signal for detection in short incubation time and works in broad pH 
range. Stability of the enzyme can be affected by nonionic detergents. [32, 389] For best 
results optimizing enzyme conjugate concentration is done as before, multiple dilutions 
are tested for optimum results [33].  
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7.5 Signal Detection  
It is important to choose the right substrate to match enzyme conjugate. The choice of 
substrate to use depends on sensitivity of the substrate solution and instrument used for 
detecting. For optimization several substrates can be experimented with. [32, 389; 33] 
The other parts for optimization are addition of the stopping reagent and correct 
wavelengths to match and measure the substrate catalysis [32, 390]. 
7.6 Kinetics and Incubation 
After optimizing assay reagents some experiments with incubation may still make the 
assay better. Aim is to achieve a high signal-to-noise ratio not just maximize the signal. 
Assay precision and sensitivity are important. Incubation times can be made shorter with 
higher concentrations of conjugate, but this can cause the prize of the assay to increase 
and result in weak signal generation. With long incubation time nonspecific signal 
generation is possible. Sandwich formats usually require shorter incubation times 
because of the use of higher capture antibody and conjugate concentrations. [32, 390] 
Optimization of the incubation time usually begins with determination how time and 
temperature have an effect on nonspecific binding and signal intensity. Nonspecific 
binding can be reduced by altering incubation time and use of more specific monoclonal 
antibodies (mAbs) produce a higher signal-to-noise ratio. Assay cross reactivity 
decreases with incubation time and increasing the incubation temperature. [32, 390] 
Balance is essential in kinetics. Factors such as reaction volume, conjugate mass, 
number of steps and matrix effects should be optimized same time with kinetics. Kinetics 
are reliant on pH, ionic strength, and temperature, particularly ion content and pH can 
have affect assay kinetics. [32, 390] 
8 Validation 
It is a process of establishing an analytical requirement and confirming that the method 
under examination has capacities consistent with application requirements [34, 8].  
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8.1 Limit of Blank and Limit of Detection  
Limit of blank (LOB) is the highest analyte concentration predicted to be found when 
sample contains no analyte. Blank sample without analyte can produce a signal that can 
be similar to a signal of sample containing low concentrations of analyte. [35]  
Limit of detection (LOD) is the lowest concentration that can be detected from the 
background by the method at a specified level of confidence. LOD is also known as 
sensitivity, minimum detectable value, detection limit and CCβ. [34, 20; 36] LOD should 
be calculated using preferably blank samples, samples containing very low concentration 
of analyte or using LOB. [34, 21; 35]. 
8.2 Intra-Assay and Inter-Assay Precision  
Assay replication is important for attaining reliable assessment of method performance 
components like precision. Validation associated with replicate analysis should be 
designed to consider variations predicted during routine use. [34, 35]  
Intra-assay precision demonstrates the replicability of wells in single assay plate. This 
will establish that samples give comparable results. [36] 
Inter-assay precision should be below 10 % and it shows replicability of assays done 
during multiple different days. This will show that the assay will be consistent and 
produce comparable results over time. [36] 
8.3 Recovery 
In recovery different sample matrices are examined for possible disturbance in analyte 
detection. Matrices can have interfering factors that can change measured analyte 
results. Recovery validation is done by spiking different matrices with known amounts of 
analyte. If average recovery is between 80 % and 120 % it is considered that analysed 
matrix has nominal effect on the assay and quantification of the analyte. [36] 
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8.4 Specificity 
This is defined as the extent to which the method can be utilized to determine analyte of 
interest without interferences from other analytes of similar behaviour. It is also known 
as cross reactivity and selectivity. [34, 8; 36] Cross reactivity can lead to inaccurate 
results such as false positives [36]. In this study specificity is seen as a cross reactivity 
and was determined using proteins similar to ricin. Proteins were abrin and RCA120 
agglutinin.                                                                                                              
9 Methods and Materials 
9.1 Work Safety 
Working with highly toxic material requires attention in work safety. It is crucial to work 
using proper protective equipment and devices and make sure that toxic material does 
not contaminate or pose a threat to worker or other personnel. All work with ricin must 
be done in laminar or biosafety cabinet. Protective gloves and coat must be worn at all 
times and gloves changed every time you remove your hands from laminar. Everything 
that comes into contact with ricin must be decontaminated using solution consisting two 
parts 10 % potassium hydroxide (KOH) and one-part ethanol. 
9.2 Chemicals and Materials 
Reagents used in this optimization and validation are found in Table 1. 
  
19 
  
Table 1. Used reagents. 
Sandwich 
ELISA 
Reagents Supplier Product Code 
R109 monoclonal antibody, B chain Robert Koch Institute   
R18 monoclonal antibody, A chain Robert Koch Institute   
Phosphate buffered saline, PBS BioRad 1610780 
Bovine Serum Albumin Heat Shock 
Reagent Grade Powder, BSA VWR 422351S 
Sodium carbonate, Na2CO3 Sigma Aldrich S7795-500G 
Sodium bicarbonate, NaHCO3  Sigma Aldrich S8875-500G 
Triton X-100 BioRad 161-0407 
Tween 20 Merck 8.22184.0500 
Pierce Streptavidin Poly-HRP Thermo Scientific 21140 
1-StepTM Ultra TMB-ELISA Thermo Scientific 34028 
Sulfuric acid, H2SO4  Merck 016-020-00-8 
Biotinylation 
R18 monoclonal antibody, A-chain Robert Koch Institute   
PBS BioRad 1610780 
EZ-Link Sulfo-NHS-LC-Biotin Thermo Scientific 21327 
Pierce Biotin Quantitation Kit Thermo Scientific 28005 
HABA/Avidin premix     
Biotinylated HRP     
Lowry assay 
Albumin Standard Thermo Scientific 23209 
DC Protein Assay Reagent B BioRad 500-0114 
DC Protein Assay Reagent A BioRad 500-0113 
Antigens 
Purified ricin Robert Koch Institute   
Purified RCA120 Robert Koch Institute   
Abrin VERIFIN   
Reagents used during the method optimizing are found in Table 2. These are the 
reagents that did not work with the method or were inferior compared to chosen reagents.  
20 
  
Table 2. Discarded reagents. 
  Reagents Supplier Product Code 
biotinylation 
EZ-Link Sulfo-NHS-Biotin Thermo Scientific 21326 
Biotin (type A) Fast Conjugation Kit Abcam ab201795 
Biotinamidohexanoyl-6-aminohexanoic 
acid N-hydroxysuccimide ester Sigma Aldrich B3295 
(+)-Biotin N-hydroxysuccinimide ester Sigma Aldrich H1759-5MG 
Ethanolamine Sigma Aldrich 398136-25ML 
Dimethyl sulfoxide Sigma Aldrich D2650-5x5ML 
blocking BlockerTM Casein Thermo Scientific 37528 
antibodies 
RA999 monoclonal antibody, A chain HyTest 2R1 
RB999 monoclonal antibody, B chain HyTest 2R1 
Apparatuses used in this study are found in Table 3. 
Table 3. Used devices. 
Devices and materials   
Thermo Scientific Multiskan Go UV/Vis spectrophotometer 
Eppendorf ThermoMixer C  Shaker 
Thermo Scientific Heraus Fresco 21 Centrifuge 
Thermo Scientific Finnpipette F1 Multichannel pipette 
Fisherbrand Elite 1-10 µl, 10-100 µl, 100-1000 µl Pipettes 
Amico Ultra MCWO Centrifugal filters 
Nunc MaxiSorp 96 microtiter plate  
Waters, Adhesive Plate Seal Plate seals 
9.3 Antibody Biotinylation and Quantitation 
Monoclonal antibody R18 for ricin A chain was biotin labelled for the sandwich ELISA. 
Biotinylation was completed using EZ-Link Sulfo-NHS-LC-Biotin from Thermo Scientific 
[29]. Biotin concentrations were quantitated using Thermo Scientifics Pierce Biotin 
Quantitation Kit [37]. 
Antibody was diluted to concentration 100 µg/500µl (200 µg/ml) using phosphate 
buffered saline (PBS). Biotin was prepared just before the use by adding 180 µl pure 
water to the vial. Volume of biotin needed for antibody biotinylation was calculated using 
the equation provided in the instructions [29]. After pipetting the needed volume solution 
was incubated in room temperature (RT) for 30 minutes.  
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Before quantitation excess biotin was removed using Amico Ultra centrifugal filters. 
Filters were washed before use. Biotinylated antibody solution was added to the vial and 
centrifuged for 10 minutes at 14 000 g. Solution was rinsed with 500 µl of PBS twice and 
centrifuged as before. After removal of biotin PBS was added up to desired volume and 
filter was turned upside down and centrifuged for 2 minutes 1000 g. 
HABA/Avid mix was prepared adding 100 µl of pure water and mixed thoroughly. 160 µl 
of PBS was added on 96-well microtiter plate and 20 µl of HABA/Avid mix on top of it. 
Absorbance was measured using wavelength 500 nm. Blanks, controls and samples 
were added in volumes of 20 µl and absorbance measured as before. Results were 
calculated using given equations from the instructions [37].  
9.4 Antibody Dilution 
Two monoclonal antibodies were used, R109 against ricin toxin B (RTB) and R18 against 
ricin toxin A (RTA). The Robert Koch Institute kindly provided both antibodies. Capture 
antibody R109 was diluted with carbonate bicarbonate buffer pH 9.6 to concentration 2.5 
µg/ml. Detection antibody was diluted with 1 % bovine serum albumin in phosphate 
buffered saline (1% BSA in PBS) to concentration 0.8 µg/ml. Antibody concentrations 
were optimized. 
9.5 Ricin Standard Preparation 
Standards were diluted from ricin standard received graciously from Robert Koch 
Institute. Dilutions were done with PBS 0.03% BSA 0.1% TritonX. Prepared standard 
concentrations after optimization were 7550 ng/ml, 755 ng/ml, 75.5 ng/ml, 7.55 ng/ml, 
0.755 ng/ml, 0.0755 ng/ml and 0.00755 ng/ml. 
9.6 Sandwich ELISA Protocol 
100 µl of diluted capture antibody R109, mAb for ricin B chain, was added to Nunc 
MaxiSorp microtiter plate. The plate was covered with adhesive plate seal and incubated 
with shaking +4 °C overnight. Without removing capture antibody 200 µl of 1% BSA in 
PBS was added and plate was incubated with shaking at +37 °C for two hours. Solution 
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was removed by gently tapping plate on tissue paper and washed 3 times with 300 µl 
PBS 0.05% Tween (PBST). Ricin standards were diluted with 0.03% BSA 0.1% TritonX 
in PBS, 100 µl of solution was added and incubated with shaking two hours in +37 °C. 
Ricin standards were removed as before taking into account solution toxicity and 
decontamination. Plate was washed 3 times with 300 µl PBST. Biotinylated detection 
antibody R18, mAb for ricin A chain, was pipetted in volume 100 µl and incubated with 
shaking in +37 °C for two hours. Washing performed as previous. 100 µl of secondary 
antibody conjugate poly-HRP, was pipetted and plate was incubated for one hour with 
shaking at +37 °C. Washing was performed as before and 100 µl of chromogenic 
substrate 3,3', 5,5;-tetramethylbenzidine (TMB) was added. Plate was incubated with 
shaking in dark for 30 minutes at RT. Reaction was stopped using 50 µl 2 M H2SO4 and 
absorbance was read in wavelength 450 nm within 30 minutes of stopping the reaction. 
9.7 Validation  
Validation was done using results from optimized sandwich ELISA method. Standards, 
blanks and samples were all done in triplicates or duplicates during multiple days. 
Standards and blanks were diluted using 0.03 % BSA 0.1 % TritonX in PBS.  
9.7.1 Recovery 
Three different matrices were used in this analysis. Matrices were milk, red wine and 
flour. Matrices were spiked with ricin up to concentrations 0 ng/ml, 0.00755 ng/ml, 0.0755 
ng/ml, 0.755 ng/ml, 7.55 ng/ml, 75.5 ng/ml, 755 ng/ml and 7550 ng/ml.  
Milk and wine were tested with two dilution solutions, the matrix itself and in PBS 0.03 % 
BSA 0.1 % TritonX. Wine was also tested after pH change. Wines pH was changed to 
8.08 using NaOH. pH changed wine was then diluted using same matrix to 
concentrations 0 ng/ml, 0.0755 ng/ml, 0.755 ng/ml, 7.55 ng/ml, 755 ng/ml and 7550 
ng/ml. 
With flour matrix an extraction was made with two solutions, 2 % acetic acid and PBST. 
0.1 g flour was weighed and spiked with ricin. Then 1 ml of extraction solution was added 
and incubated in RT for 30 minutes. Solution was removed and diluted with matrix as 
mentioned before. 
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9.7.2 Specificity 
Two other protein toxins RCA120 and abrin were analysed using optimized sandwich 
ELISA for ricin. Assay was done as before but tested concentrations were for RCA120 
1000 ng/ml, 100 ng/ml, 50 ng/ml, 25 ng/ml, 10 ng/ml, 5 ng/ml, 1 ng/ml and 0 ng/ml. For 
abrin concentrations were approximately 4000 ng/ml, 400 ng/ml, 40 ng/ml, 20 ng/ml, 10 
ng/ml, 5 ng/ml, 1 ng/ml and 0 ng/ml. 
10 Results 
10.1 Antibody Biotinylation and Quantitation 
EZ-Link Sulfo-NHS-Biotin was the first biotin used in the biotinylation of antibodies. It had 
been used successfully in earlier sandwich ELISA, but did not work in this study. 
Antibodies biotinylated with sulfo-NHS-biotin yielded lower absorption values, which 
could have been due to the short spacer arm hindering the attaching of biotin to 
antibodies. 
The second biotin used was Biotin (type A) Fast Conjugation Kit. It had only reagents for 
three biotinylations and in comparison to other kits it was expensive. Results were similar 
to other discarded biotins.  
The third biotin used was (+)-Biotin N-hydroxysuccinimide ester. In this biotinylation the 
biotin was diluted to dimethyl sulfoxide (DMSO) and ethanolamine was used to bind 
excess biotin after biotinylation. Antibodies bind with this biotin did not give higher OD450 
values than 0.14.  
The fourth biotin used was Biotinamidohexanoyl-6-aminohexanoic acid N-
hydroxysuccimide ester. Biotin was diluted in DMSO. Biotinamidohexanoyl-6-
aminohexanoic acid N-hydroxysuccimide ester had longest spacer arm out of the five 
biotins. OD450 results using this biotin can be found in Appendix 1. Absorption was 
similar to EZ-Link Sulfo-NHS-LC-Biotin.  
Biotin chosen for use in this study was EZ-Link Sulfo-NHS-LC-Biotin. It has relatively 
long spacer arm and easy to use no weigh -format. Biotin is attached to the antibodies 
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easily, giving proper biotin molecule quantities during quantitation. Antibodies 
biotinylated with EZ-Link Sulfo-NHS-LC-Biotin gave high absorption results and 
continued working through rest of the optimization.  
At the beginning of this study the assay yielded no colour reaction. This lead to 
suspecting the preservability of biotinylated antibodies. Biotinylated antibody made in 
January 2017 (170105MaK01) was tested to see how long the reagent would work. Test 
was done in September the same year and gave no results (Table 4).  
Table 4. Biotinylated antibody tested using ricin concentration of 755 pg/ml.  
  OD450 Mean 
Blank 0.1051 0.0985 0.1039 0.0994 0.1017 
755 pg/ml 0.0880 0.1035 0.0775 0.1026 0.0929 
Biotinylated antibody stored in refrigerator at +4 ºC did not last nine months. 
10.2 ELISA Protocol Optimization 
Initial analysis was done using a different sandwich ELISA protocol. This protocol was 
based on the one used by Robert Koch Institute, described in reference 3: 
Characterization of Ricin and R. communis Agglutinin Reference Materials. Protocol was 
tested multiple times with no colour change after TMB incubation. After successful 
biotinylation first results were obtained (Table 5).  
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Table 5. First visible absorbance results. 
Ricin (µg/ml) OD450 
Blank 
0.0491 
0.0546 
5.1 
0.1226 
0.1205 
0.1273 
0.1308 
0.1136 
0.1167 
Absorption results were very low, comparing to the concentration of ricin 5.1 µg/ml. 
10.2.1 Blocking Buffer Optimization 
Because of the low absorption values attention was directed towards possible disturbing 
factors. These factors were blocking buffer, biotinylation and coating buffer. Blocking 
buffer was changed from casein to 1 % BSA in PBS. Results in Table 6 were higher than 
using casein as blocking buffer. 
Table 6. Casein blocker replaced with 1 % BSA in PBS OD450 results. 
 mAb B c (µg/ml)  Mean mAb B c (µg/ml) 
Ricin (µg/ml) 2.5 10 20 2.5 10 20 
Blank 
0.0517 0.0532 0.0534 
0.0516 0.0625 0.0563 
0.0514 0.0718 0.0592 
0.051 
0.1719 0.1300 0.1332 
0.1488 0.1323 0.1417 0.1431 0.1389 0.1536 
0.1313 0.1281 0.1383 
5.1 
0.2045 0.2138 0.2154 
0.2129 0.2056 0.2088 0.2128 0.1925 0.2119 
0.2215 0.2106 0.1990 
In blocking buffer test the concentration of coating antibody was tested also. Coating 
concentration 2.5 µg/ml gave highest results of three concentrations tested. 
Blocking buffer change did not give adequate absorption results. Coating buffer change 
were considered. Coating was done using antibody diluted in PBS. Multiple other ELISA 
methods use alkaline coating buffer.  
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10.2.2 ELISA Protocol Change 
A protocol used by Spiez laboratory in Switzerland had alkaline coating buffer, 1 % BSA 
in PBS as blocking buffer. Spiez protocol had also longer incubation times and incubation 
was done in higher temperatures than previously used protocol from RKI. Protocol was 
tested and the results were similar to blocking buffer change results (Table 7). 
Table 7. Results after switching the protocol from RKI to Spiez 
Ricin (µg/ml) 
mAb B (µg/ml) 
2.5 Mean 10 Mean 
Blank 
0.0542 
0.0523 
0.0499 
0.0541 0.0511 0.0575 
0.0516 0.0548 
0.0051 
0.1646 
0.1991 
0.1845 
0.1764 0.2540 0.1889 
0.1786 0.1558 
0.051 
0.2056 
0.2676 
0.3185 
0.3311 0.2293 0.3685 
0.3679 0.3062 
0.51 
0.2771 
0.2619 
0.2720 
0.2651 0.2681 0.2919 
0.2405 0.2313 
5.1 
0.2609 
0.2620 
0.2962 
0.2919 0.2513 0.3021 
0.2737 0.2773 
A new biotinylation of antibodies was made using EZ-Link Sulfo-NHS-LC-Biotin and 
protocol was tested again. Results on Table 8 were significantly better with higher 
absorption reads. 
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Table 8. Results after EZ-Link Sulfo-NHS-LC-Biotin biotinylation with new protocol 
Ricin (µg/ml) OD450 Mean OD450 
0 
0.0454 
0.0477 0.0505 
0.0473 
0.000755 
0.4785 
0.5004 0.5268 
0.4959 
0.00755 
1.2015 
1.4964 1.4995 
1.7882 
0.0755 
1.9507 
1.7812 1.8581 
1.5347 
0.755 
1.7893 
1.8124 2.0155 
1.6323 
7.55 
2.1167 
1.9654 1.8545 
1.9249 
10.2.3 Antibody Comparison and Concentration Optimization 
Before testing, antibody protein concentration was measured with Lowry assay.  
While developing ELISA method another antibody pair was tested. Antibody pair was 
HyTest RA999 and RB999. HyTest antibodies were used slightly differently from RKI 
antibodies: coating was done using RA999 against A chain and detection with EZ-Link 
Sulfo-NHS-LC-Biotin biotinylated RB999 against B chain. This was done because of 
HyTest recommendations. Results can be seen in Figure 8 and Appendix 1. RKI 
antibodies detected lower ricin concentrations than HyTest antibodies which could 
measure ricin from 0.76 ng/ml onwards. 
Chosen antibody pair was RKI R109 and R18 biotinylated with EZ-Link Sulfo-NHS-LC-
Biotin. Earlier R109 concentration was optimized to 2.5 µg/ml (Table 6, Table 7, and 
Appendix 1). Results for detection antibody optimization measurements are in Appendix 
2. Optimum detection antibody concentration was 0.8 µg/ml. This concentration gave 
high absorption reads compared to other tested antibody concentrations.  
Optimized antibody concentrations were for coating antibody R109 2.5 µg/ml and for 
detection antibody R18 0.8 µg/ml. 
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10.2.4 Conjugation Enzyme, poly-HRP, Optimization 
Conjugation enzyme optimization results are found in Appendix 3. Concentration 1 ng/ml 
of poly-HRP improved detection of the lowest ricin standard 7.55 pg/ml and had higher 
absorption results throughout all standards. Poly-HRP concentration 1 ng/ml was chosen 
for optimized assay. 
10.3 Validation 
For validation calculations, a free program called MyAssays [38], was used for four 
parameter logistic curve fitting. With fitted curves absorption values were modified to 
concentration values. 
Four parameter logistic (4PL) regression uses equation:  
  𝑦 = 𝑑 +
𝑎−𝑑
1+(
𝑥
𝑐
)𝑏
   (1) 
where 
x is independent variable 
y is the dependent variable 
a is the minimum value possible to obtained  
d is the maximum value possible to obtained  
c is the point of inflection, halfway between a and d  
b is slope of the curve. [38] 
To solve x from the equation [38]: 
  𝑥 = 𝑐(
𝑎−𝑑
𝑦−𝑑
− 1)
1
𝑏   (2) 
These calculations were done by the MyAssays program. 
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10.3.1 Limit of Blank and Limit of Detection 
Limit of blank was calculated using multiple blank concentration results found in Table 9. 
Blank concentrations were calculated from results found in Appendix 4. 
Table 9. Calculated concentration, average and standard deviation for blanks. 
Blank c (pg/ml) 
0.287 1.914 1.810 0.754 
1.060 0.968 1.686 1.645 
1.851 0.685 2.432 1.117 
0.618 0.842 0.914 1.117 
0.987 1.060 0.932   
0.301 0.772 0.842   
0.568 1.385 1.173   
3.423 1.173 2.321   
2.610 0.454 0.987   
0.914 1.230 0.772   
Mean 1.224 
Standard deviation 0.695 
CV % 57 
Equation used for the calculations was. 
  𝐿𝑂𝐵 = 𝑚𝑒𝑎𝑛𝑏𝑙𝑎𝑛𝑘 + 1.645 × 𝑆𝐷𝑏𝑙𝑎𝑛𝑘  (3) 
where 
meanblank is the average result of all measured blanks 
SDblank is standard deviation of blanks [35]. 
Limit of detection was calculated using the equation 
  𝐿𝑂𝐷 = 𝐿𝑂𝐵 + 1.645 × 𝑆𝐷𝑙𝑜𝑤 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑠𝑎𝑚𝑝𝑙𝑒 (4) 
where 
SDlow concentration sample is standard deviation result of lowest measured concentration [35]. 
LOD was calculated using the lowest ricin sample 2.5 pg/ml (Table 10.). Results used 
for the concentration calculations are found in Appendix 5. 
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Table 10. Three low ricin concentration results.  
Ricin pg/ml 2.5 4 7.55 
c pg/ml 
2.906 3.861 8.596 
2.723 3.738 8.167 
2.814 4.035 8.106 
2.062 3.665 7.241 
2.520 3.787 7.447 
2.234 3.641 7.418 
2.723 4.671 6.125 
Mean pg/ml 2.569 3.914 7.586 
SD 0.314 0.359 0.809 
CV % 12 9.2 11 
Calculated LOB was 2.4 pg/ml and LOD was 2.9 pg/ml.  
This meant that highest analyte concentration predicted to be found for this sandwich 
ELISA when sample contains no analyte was 2.4 pg/ml. Minimum detectable 
concentration for this sandwich ELISA was 2.9 pg/ml. 
10.3.2 Intra-Assay and Inter-Assay Precision 
Intra-assay precision 12 different ricin standards and all standards had eight duplicate 
standards. Results are found in Appendix 6 and calculated results in Table 11. 
Table 11. Intra-assay precision results. 
pg/ml   Mean (pg/ml) SD CV % 
0 Sample 0 5.31 0.46 8.6 
3.75 Sample 1 7.07 0.72 10 
7.55 Sample 2 9.96 1.14 11 
15 Sample 3 13.80 0.54 3.9 
37.5 Sample 4 37.72 8.51 23 
75.5 Sample 5 72.76 14.66 20 
375 Sample 6 271.48 14.27 5.3 
755 Sample 7 895.04 96.67 11 
3750 Sample 8 5179.13 2591.06 50 
7550 Sample 9 10733.75 11241.15 105 
75500 Sample 10 12118.88 2424.34 20 
375000 Sample 11 12510.00 2913.28 23 
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Results were relatively good. Half of the CV % results were close or below 10 % and the 
other half around 20 %. Only results for samples 8 and 9 were inferior. This could be 
because of a pipetting error. Samples 8 and 9 are also on the angle of the curve were 
saturation begins. Samples 10 and 11 are on the plain part of the curve and results thus 
closer to ideal. One reason for high CV % can be that the logarithmic scale can make 
even small differences between OD450 values larger. 
Inter-assay precision had 17 determinations during 4 different days. Results can be 
found in Appendix 7 and calculated results in Table 12. 
Table 12. Inter-assay precision results. 
Ricin (pg/ml) 7.55 35 75.5 755 7550 
pg/ml 
6.9 37.2 67.8 784.7 3389.0 
5.9 38.7 74.1 638.1 6376.0 
5.9 36.4 79.9 872.7 > Curve 
6.9 38.3 71.7 1372.0 3133.0 
7.2 39.7 66.7 692.0 3071.0 
6.5 38.5 75.6 555.5 > Curve 
4.7 38.6 105.4 699.9 6706.0 
7.7 36.7 83.3 739.3 > Curve 
5.7 34.2 69.0 716.0 4355.0 
8.5 34.1 68.6 724.1 4389.0 
5.3 59.7 68.4 935.1 4457.0 
4.6 33.9 66.2 704.5 > Curve 
6.1 33.5 63.3 749.1 4953.0 
7.6 34.4 66.0 798.7 4395.0 
7.1 34.7 82.3 696.5 3413.0 
11.0 36.8 71.3 638.3 8455.0 
6.7 36.2 70.2 987.4 > Curve 
Mean pg/ml 6.7 37.7 73.5 782.6 4757.7 
SD 1.5 6.0 10.1 186.0 1646.2 
CV % 23 16 14 24 35 
All inter-assay precision results were over the preferred 10 % limit. This shows that 
replicability of the assay is not very good. Especially the higher concentrations gave 
worse results indicating that saturation hampers the assay precision. Result marked as 
> Curve means that the value is greater than upper asymptote of the four parameter 
logistic. 
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10.3.3 Measurement from Spiked Matrices 
Average recovery % results for three different matrices, milk, wine and flour can be found 
in Table 13, 14, 15 and 16. Results were calculated using fitted curves and 
concentrations found in Appendix 8. 
Table 13. Ricin spiked on milk recovery %. 
Sample Average recovery % Sample Average recovery % 
MILK, diluted 
with milk 
matrix 
1 21 
MILK, diluted 
with 0.03 % 
BSA 0.1% 
TritonX in PBS 
    
2 8.5 2 26 
3 15 3 15 
4 85 4 9.6 
5 450 5 5.4 
6 6.3 6 1.3 
7 0.5 7 0.1 
Two different dilutions gave somewhat different results. When diluting the spiked milk 
with milk it seems to have slightly higher results than diluting with 0.03 % BSA 0.1% 
TritonX in PBS. It also has recovery of 450 % hinting that the method is not exact for 
different matrices. 
Table 14. Ricin spiked wine recovery %. 
Sample Average recovery % Sample Average recovery % 
WINE, diluted 
with wine 
matrix 
1 18 
WINE, diluted 
with 0.03 % 
BSA 0.1% 
TritonX in PBS 
    
2 3.0 2 11 
3 0.22 3 14 
4 0.03 4 10 
5 0.09 5 8.2 
6 0.00 6 3.6 
7 0.05 7 0.2 
With wine matrix results seem to be opposite from milk results. Diluting the spiked wine 
with 0.03 % BSA 0.1% TritonX in PBS seems to improve recovery %. This might indicate 
that wine has something that hinders assay and when diluted with optimum solution that 
interference diminishes.  
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Table 15. Ricin spiked pH changed wine recovery % 
Sample Average recovery % 
WINE pH 8 
    
2 0.04 
3 1.92 
4 0.02 
    
6 0.02 
7 0.06 
Changing the pH of the wine seems not to increase recovery, so assay hindering factor 
is probably not pH level of the matrix. 
Table 16. Ricin spiked flour recovery %. 
Sample Average recovery % Sample Average recovery % 
FLOUR, 
extraction with 
2 % acetic 
acid 
1 22 
FLOUR, 
extraction with   
PBST 
1 25 
2 7.0 2 1.9 
3 0.29 3 0.1 
4 0.03 4 0.4 
5 0.01 5 0.3 
6 0.003 6 0.2 
7 0.01 7 0.1 
Flour extraction with PBST gives overall better recovery % than with 2 % acetic acid. 
More neutral extraction solution improves the recovery of ricin.  
Flour matrix seems to be difficult matrix to detect ricin compared to other two matrices. 
The other two yield higher recoveries, but milk appears to be the easiest to detect ricin 
from.  
Ricin could be enriched from the spiked samples using for example antibody coated 
magnetic beads, to enhance recovery % from the different matrices. 
10.3.4 Specificity 
Results for ricin sandwich ELISA cross-reactivity with agglutinin can be found in Table 
17. Absorbance of concentrations between 1-10 ng/ml do not differ from blank. First 
detectable agglutinin concentration is 25 ng/ml.   
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Table 17. Measured OD450 values for agglutinin RCA120 when using ricin sandwich ELISA. 
Agglutinin (ng/ml) OD450 Mean 
0 0.0580 0.0573 0.0566 0.0573 
1 0.0536 0.0563 0.0553 0.0551 
5 0.0564 0.0610 0.0606 0.0593 
10 0.0581 0.0566 0.0579 0.0575 
25 0.0742 0.0955 0.0615 0.0771 
50 0.0802 0.0718 0.0664 0.0728 
100 0.0671 0.0695 0.0834 0.0733 
1000 0.1689 0.1404 0.1631 0.1575 
Abrin results (Table 18) show that all measured concentrations were same as blank. 
Abrin used in the test was not purified and may contain other proteins. 
Table 18. Measured OD450 values for abrin when using ricin ELISA. 
Abrin (ng/ml) OD450 Mean 
0 0.0921 0.0982 0.1045 0.0983 
1 0.1012 0.0923 0.0949 0.0961 
5 0.0933 0.0913 0.0869 0.0905 
10 0.0899 0.0910 0.0928 0.0912 
20 0.0898 0.0907 0.0909 0.0905 
40 0.0893 0.0857 0.0988 0.0913 
400 0.0853 0.0894 0.0929 0.0892 
4000 0.0818 0.0913 0.0864 0.0865 
Agglutinin 1–1000 ng/ml and abrin 1–4000 ng/ml were assayed with ricin sandwich 
ELISA.  Abrin was not cross-reacting with the developed ricin ELISA. Agglutinin was 
found to have some cross-reactivity when concentration of agglutinin was 25 ng/ml or 
higher. 
11 Discussion and Conclusion 
This study concentrated on developing enzymatic methods of ricin determination. 
Particularly on method optimization and validation of sandwich ELISA. Purpose was to 
improve existing method to attain reliable results in ricin determination and provide 
VERIFIN with detailed working instruction. The optimization work concentrated on 
antibody biotinylation, reaction buffers, antibody concentrations and conjugate enzyme 
concentration. After optimizing the method, the focus was on method validation. 
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Validation focused on limit of blank, limit of detection, assay precision, recovery and 
specificity. 
Method optimization was successful and developed assay is capable of detecting ricin 
easily between concentrations 7.6 pg/ml–7.6 µg/ml when using standard dilution solution 
0.03 % BSA 0.1 % TritonX in PBS. Suitable buffer for coating was found to be carbonate 
bicarbonate buffer and for blocking 1 % BSA in PBS. Best tested concentrations for 
antibodies were 2.5 µg/ml for capture antibody and 0.8 µg/ml for detection antibody. 
Conjugate enzyme poly-HRP concentration was most suitable at 1 ng/ml. Optimal biotin 
for antibody labelling was EZ-Link Sulfo-NHS-LC-Biotin. 
Limit of detection was 2.9 pg/ml. Intra-assay precision varied from 3.9 % to 105 %. Inter-
assay precision was between 14 % and 35 %. Precisions for both were higher than 10 
% which indicates that the replicability of the assay is not reliable in current work. 
Precision could be positively influenced by washing microplates using plate washer 
rather than washing with pipetting by hand, and possible changing to electronic pipette.  
Measurement with spiked matrices from milk, wine and flour yielded low results. Milk 
gave the best results varying between 0.1–450 %. Because recovery was not between 
80 % and 120 % it can be considered that analysed matrices had substantial effect on 
the ELISA assay, and, thus quantification of the ricin. To improve recovery % sample 
containing ricin could be concentrated and then diluted using PBST or analyte could be 
enriched with antibodies. 
No abrin cross-reactivity was observed with the assay and agglutinin reacted with the 
ricin antibodies when concentration of it reached 25 ng/ml. This indicates that used 
antibodies were highly specific for ricin identification. When considering all validation 
results the assay did not yield repeatable accurate results in the current work. 
The goal of the thesis was met providing VERIFIN with working sandwich ELISA method 
detecting ricin in low concentrations. Even though validation was not optimal, with some 
changes it can be improved, and the optimized ELISA method will yield precise results.  
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RKI and HyTest antibody comparison results 
 
 
 
 
  
Ricin Coating mAb Concentratio (ng/ml) Mean
0 0.0503 0.0384 0.0392 0.0388
0.00755 0.0398 0.0368 0.0483 0.0416
0.0755 0.0666 0.0701 0.0587 0.0684
0.755 0.2473 0.2428 0.2619 0.2524
7.55 0.5629 0.4430 0.5232 0.5431
75.5 0.1187 0.4948 0.4914 0.4931
0 0.0393 0.0411 0.1965 0.0402
0.00755 0.0356 0.0346 0.0449 0.0384
0.0755 0.0353 0.0735 0.0757 0.0746
0.755 0.2047 0.2583 0.2458 0.2521
7.55 0.4389 0.5072 0.4492 0.4441
75.5 0.4962 0.3751 0.5314 0.5138
0 0.0494 0.0459 0.0447 0.0467
0.0051 0.0475 0.0474 0.0470 0.0473
0.051 0.0636 0.0606 0.0570 0.0604
0.51 0.1664 0.1706 0.1736 0.1702
5.1 0.5883 0.4276 0.4579 0.4428
51 0.5008 0.5037 0.4852 0.4930
Ricin Coating mAb Concentratio (ng/ml) Mean
0 0.0391 0.0367 0.0379
0.00755 0.0347 0.0342 0.0345
0.0755 0.0349 0.0343 0.0346
0.755 0.0453 0.0626 0.0540
7.55 0.1559 0.2131 0.2131
75.5 0.4251 0.1582 0.4251
ODT450
B3249 HyTest 2,5 µg/ml
ODT450
RKI 2,5 µg/mlB2578
B3249 RKI 2,5 µg/ml
B3249 RKI 5 µg/ml
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 Ricin Coating mAb Detection mAb Ricin concentration (ng/ml) Mean
0 0.0861 0.0468 0.0469 0.0469
0.00755 0.0495 0.0467 0.0484 0.0482
0.0755 0.0818 0.0794 0.1415 0.0806
0.755 0.2553 0.2539 0.3020 0.2546
7.55 0.4691 0.4645 0.4627 0.4654
75.5 0.5570 0.7163 0.5509 0.5540
 Ricin Coating mAb Detection mAb Ricin concentration (ng/ml) keskiarvo
0 0.0478 0.0531 0.0460 0.0490
0.00755 0.0483 0.0505 0.0493 0.0494
0.0755 0.0923 0.0911 0.0923 0.0919
0.755 0.2973 0.3192 0.2998 0.3054
7.55 0.4975 0.4859 0.5127 0.4987
75.5 0.7178 0.5666 0.5623 0.5645
 Ricin Coating mAb Detection mAb Ricin concentration (ng/ml) keskiarvo
0 0.0483 0.0508 0.0455 0.0482
0.00755 0.0499 0.0446 0.0463 0.0469
0.0755 0.0496 0.0477 0.0476 0.0483
0.755 0.0602 0.0570 0.0605 0.0592
7.55 0.1704 0.1976 0.1674 0.1689
75.5 0.7497 0.4964 0.7578 0.7538
 Ricin Coating mAb Detection mAb Ricin concentration (ng/ml) keskiarvo
0 0.0463 0.0462 0.0469 0.0465
0.00755 0.0473 0.0446 0.0484 0.0468
0.0755 0.0485 0.0501 0.0500 0.0495
0.755 0.0815 0.0887 0.0807 0.0836
7.55 0.2761 0.3013 0.3705 0.3160
75.5 0.8825 0.8123 0.6743 0.8474
ODT450
ODT450
ODT450
ODT450
B3249 RKI 2,5 µg/ml
RKI 1 µg/ml + 
Sulfo-NHS-LC-
Biotin
B3249 RKI 2,5 µg/ml
RKI 1 µg/ml + 
Biotinamidohexa
noyl-6-
aminohexanoic 
acid NHS ester
B3249 HyTest 2,5 µg/ml
HyTest 1 µg/ml + 
Sulfo-NHS-LC-
Biotin
B3249 HyTest 2,5 µg/ml
HyTest 1 µg/ml + 
Biotinamidohexa
noyl-6-
aminohexanoic 
acid NHS ester
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Detection antibody optimization results 
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.2 
0 0.0665 0.0512 0.05885 
0.00755 0.0496 0.0494 0.0495 
0.0755 0.0612 0.0749 0.06805 
0.755 0.6705 0.2518 0.4612 
7.55 0.6163 0.7564 0.68635 
75.5 0.6740 0.6216 0.6478 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.3 
0 0.0516 0.0457 0.04865 
0.00755 0.0502 0.0457 0.04795 
0.0755 0.0673 0.0834 0.07535 
0.755 0.2835 0.4024 0.3430 
7.55 0.5005 0.4952 0.49785 
75.5 0.6194 0.6329 0.6262 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.4 
0 0.0519 0.0529 0.0524 
0.00755 0.0492 0.0492 0.0492 
0.0755 0.0603 0.0647 0.0625 
0.755 0.2850 0.2404 0.2627 
7.55 0.6309 0.4896 0.56025 
75.5 0.7926 0.6205 0.7066 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.5 
0 0.0441 0.0528 0.04845 
0.00755 0.0476 0.0504 0.049 
0.0755 0.0685 0.0686 0.06855 
0.755 0.2552 0.2483 0.2518 
7.55 0.5091 0.5427 0.5259 
75.5 0.6207 0.6111 0.6159 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.6 
0 0.0469 0.0444 0.04565 
0.00755 0.0478 0.0460 0.0469 
0.0755 0.0716 0.0678 0.0697 
0.755 0.3006 0.2814 0.2910 
7,55 0,5283 0,6703 0,5993 
75,5 0,6081 0,6824 0,6453 
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Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.7 
0 0.0441 0.0440 0.04405 
0.00755 0.0447 0.0453 0.045 
0.0755 0.0688 0.0623 0.06555 
0.755 0.2573 0.2567 0.2570 
7.55 0.7054 0.6261 0.66575 
75.5 0.8127 0.5706 0.6917 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.8 
0 0.0451 0.0437 0.0444 
0.00755 0.0474 0.0467 0.04705 
0.0755 0.0715 0.0717 0.0716 
0.755 0.3721 0.2931 0.3326 
7.55 0.7862 0.7982 0.7922 
75.5 0.7505 0.7815 0.7660 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
0.9 
0 0.0628 0.052 0.0574 
0.00755 0.0501 0.0505 0.0503 
0.0755 0.0719 0.0620 0.06695 
0.755 0.2184 0.2204 0.2194 
7.55 0.4728 0.4508 0.4618 
75.5 0.5787 0.5818 0.5803 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
1 
0 0.0460 0.0503 0.04815 
0.00755 0.0496 0.0471 0.04835 
0.0755 0.0692 0.0658 0.0675 
0.755 0.2142 0.2158 0.2150 
7.55 0.4388 0.5419 0.49035 
75.5 0.5778 0.5826 0.5802 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
1.1 
0 0.0482 0.0539 0.05105 
0.00755 0.0486 0.0469 0.04775 
0.0755 0.0755 0.0691 0.0723 
0.755 0.2079 0.2102 0.2091 
7.55 0.4475 0.4626 0.45505 
75.5 0.5641 0.5749 0.5695 
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Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
1.2 
0 0.0443 0.0461 0.0452 
0.00755 0.0479 0.0523 0.0501 
0.0755 0.0673 0.0690 0.06815 
0.755 0.2699 0.2160 0.2430 
7.55 0.4680 0.4805 0.47425 
75.5 0.6749 0.5724 0.6237 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
1.3 
0 0.0489 0.0487 0.0488 
0.00755 0.0488 0.0483 0.04855 
0.0755 0.0694 0.0677 0.06855 
0.755 0.2411 0.2208 0.2310 
7.55 0.5960 0.5762 0.5861 
75.5 0.5572 0.5242 0.5407 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
1.4 
0 0.0542 0.0526 0.0534 
0.00755 0.0504 0.0485 0.04945 
0.0755 0.0685 0.0675 0.068 
0.755 0.2089 0.1901 0.1995 
7.55 0.5443 0.6097 0.577 
75.5 0.5056 0.5330 0.5193 
     
Detection mAb c (µg/ml) Ricin (ng/ml) OD450 Mean 
1.5 
0 0.0485 0.0488 0.04865 
0.00755 0.0497 0.0476 0.04865 
0.0755 0.0641 0.0643 0.0642 
0.755 0.1712 0.1916 0.1814 
7.55 0.4153 0.4712 0.44325 
75.5 0.6444 0.5017 0.5731 
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Poly-HRP optimization results 
poly-HRP c (ng/ml) 
Ricin (ng/ml) ODT450 Mean 
0.25 
0 0.0463 0.0476 0.0481 0.047333 
0.00755 0.0472 0.0503 0.0490 0.0488 
0.02 0.0513 0.0563 0.0494 0.0523 
0.0755 0.0626 0.0706 0.0648 0.0637 
0.755 0.1776 0.2217 0.1756 0.1766 
7.55 0.3012 0.4051 0.3997 0.4024 
75.5 0.5048 0.4962 0.4832 0.4947 
      
poly-HRP c (ng/ml) Ricin (ng/ml) ODT450 Mean 
0.5 
0 0.0488 0.0502 0.0503 0.0498 
0.00755 0.0509 0.0662 0.0517 0.0513 
0.02 0.0570 0.0586 0.0597 0.0584 
0.0755 0.0849 0.0862 0.0914 0.0856 
0.755 0.3428 0.3290 0.3407 0.3375 
7.55 0.7637 0.7662 1.0033 0.7650 
75.5 0.9354 0.9554 0.9290 0.9399 
      
poly-HRP c (ng/ml) Ricin (ng/ml) ODT450 Mean 
0.75 
0 0.0517 0.0500 0.0505 0.0507 
0.00755 0.0542 0.0565 0.0546 0.0551 
0.02 0.0636 0.0678 0.0621 0.0645 
0.0755 0.1099 0.1109 0.1113 0.1107 
0.755 0.4802 0.5176 0.4687 0.4745 
7.55 1.1893 1.1349 1.1530 1.1440 
75.5 2.2191 1.3727 1.6219 1.4973 
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poly-HRP c (ng/ml) Ricin (ng/ml) ODT450 Mean 
1 
0 0.0484 0.0502 0.0537 0.0508 
0.00755 0.0530 0.0547 0.0553 0.0543 
0.02 0.0657 0.0654 0.0757 0.0656 
0.0755 0.1681 0.1268 0.2771 0.1475 
0.755 0.6583 0.5798 0.5980 0.5889 
7.55 1.3249 1.3282 1.3683 1.3405 
75.5 2.6349 1.5819 1.6129 1.5974 
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MyAssays LOB results 
 
         
       
a 0.05132 
       b 0.8311 
       c 138.2 
       d 0.458 
       MSE 0.00001098 
       R² 0.9311 
       SS 0.0003185 
       SYX 0.003569 
         
         
         
         
         
         
         
         
         
         
Calibrator Wells Conc. Raw SEM Backfit Recovery 
% 
  
Standard1 A1 0 0.0458 0.0021 < Curve -   
B1 0.0456 < Curve -   
C1 0.0487 < Curve -   
D1 0.049 < Curve -   
E1 0.0498 < Curve -   
F1 0.0508 < Curve -   
G1 0.0583 1.06 -   
H1 0.0623 1.851 -   
Standard2 A2 2.5 0.0671 0.000535 2.906 116.2   
B2 0.0663 2.723 108.9   
C2 0.0667 2.814 112.6   
D2 0.0633 2.062 82.48   
E2 0.0654 2.52 100.8   
F2 0.0641 2.234 89.37   
G2 Flagged - -   
H2 0.0663 2.723 108.9   
Standard3 A3 4 Flagged 0.00054 - -   
B3 0.0711 3.861 96.53   
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0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.1
2.5
M
e
a
s
u
re
m
e
n
t
Concentration
4PL Standard
Appendix 4 
  2 (3) 
 
  
C3 0.0706 3.738 93.46   
D3 0.0718 4.035 100.9   
E3 0.0703 3.665 91.62   
F3 0.0708 3.787 94.68   
G3 0.0702 3.641 91.01   
H3 0.0743 4.671 116.8   
Standard4 A4 7.55 0.0881 0.00104 8.596 113.9   
B4 0.0867 8.167 108.2   
C4 0.0865 8.106 107.4   
D4 0.0836 7.241 95.91   
E4 0.0843 7.447 98.64   
F4 0.0842 7.418 98.25   
G4 0.0797 6.125 81.12   
H4 Flagged - -   
         
         
Sample Wells Raw Conc. Conc. 
(Average) 
%CV SD SEM 
 
Unknown1 A5 0.0451 < Curve - - - -  
Unknown2 B5 0.0437 < Curve - - - -  
Unknown3 C5 0.0484 < Curve - - - -  
Unknown4 D5 0.0502 < Curve - - - -  
Unknown5 E5 0.0537 0.2868 0.2868 - - 0  
Unknown6 F5 0.0474 < Curve - - - -  
Unknown7 G5 0.0474 < Curve - - - -  
Unknown8 H5 0.0466 < Curve - - - -  
Unknown9 A6 0.0458 < Curve - - - -  
Unknown10 B6 0.0456 < Curve - - - -  
Unknown11 C6 0.0487 < Curve - - - -  
Unknown12 D6 0.049 < Curve - - - -  
Unknown13 E6 0.0498 < Curve - - - -  
Unknown14 F6 0.0508 < Curve - - - -  
Unknown15 G6 0.0583 1.06 1.06 - - 0  
Unknown16 H6 0.0623 1.851 1.851 - - 0  
Unknown17 A7 0.0558 0.6175 0.6175 - - 0  
Unknown18 B7 0.0579 0.9866 0.9866 - - 0  
Unknown19 C7 0.0538 0.3014 0.3014 - - 0  
Unknown20 D7 0.0555 0.5676 0.5676 - - 0  
Unknown21 E7 0.0693 3.423 3.423 - - 0  
Unknown22 F7 0.0658 2.61 2.61 - - 0  
Unknown23 G7 0.0575 0.9138 0.9138 - - 0  
Unknown24 H7 0.0626 1.914 1.914 - - 0  
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Unknown25 A8 0.0578 0.9683 0.9683 - - 0  
Unknown26 B8 0.0562 0.6852 0.6852 - - 0  
Unknown27 C8 0.0571 0.8422 0.8422 - - 0  
Unknown28 D8 0.0583 1.06 1.06 - - 0  
Unknown29 E8 0.0567 0.7716 0.7716 - - 0  
Unknown30 F8 0.06 1.385 1.385 - - 0  
Unknown31 G8 0.0589 1.173 1.173 - - 0  
Unknown32 H8 0.0548 0.4544 0.4544 - - 0  
Unknown33 A9 0.0592 1.23 1.23 - - 0  
Unknown34 B9 0.0621 1.81 1.81 - - 0  
Unknown35 C9 0.0615 1.686 1.686 - - 0  
Unknown36 D9 0.065 2.432 2.432 - - 0  
Unknown37 E9 0.0575 0.9138 0.9138 - - 0  
Unknown38 F9 0.0576 0.9319 0.9319 - - 0  
Unknown39 G9 0.0571 0.8422 0.8422 - - 0  
Unknown40 H9 0.0589 1.173 1.173 - - 0  
Unknown41 A10 0.0463 < Curve - - - -  
Unknown42 B10 0.0461 < Curve - - - -  
Unknown43 C10 0.0645 2.321 2.321 - - 0  
Unknown44 D10 0.0579 0.9866 0.9866 - - 0  
Unknown45 E10 0.0567 0.7716 0.7716 - - 0  
Unknown46 F10 0.0566 0.7542 0.7542 - - 0  
Unknown47 G10 0.0613 1.645 1.645 - - 0  
Unknown48 H10 0.0586 1.117 1.117 - - 0  
Unknown49 A11 0.0586 1.117 1.117 - - 0  
         
The highlighted samples are outside the range of the curve fit and/or the range of the standards. 
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MyAssays LOD results 
        
 
      
a 0.05132 
      b 0.8311 
      c 138.2 
      d 0.458 
      MSE 0.00001098 
      R² 0.9311 
      SS 0.0003185 
      SYX 0.003569 
        
        
        
        
        
        
        
        
        
Calibrator Conc. Wells Raw SEM Backfit Recovery 
% 
 
Standard1 0 A1 0.0458 0.0021 < Curve -  
B1 0.0456 < Curve -  
C1 0.0487 < Curve -  
D1 0.049 < Curve -  
E1 0.0498 < Curve -  
F1 0.0508 < Curve -  
G1 0.0583 1.06 -  
H1 0.0623 1.851 -  
Standard2 2.5 A2 0.0671 0.000535 2.906 116.2  
B2 0.0663 2.723 108.9  
C2 0.0667 2.814 112.6  
D2 0.0633 2.062 82.48  
E2 0.0654 2.52 100.8  
F2 0.0641 2.234 89.37  
G2 Flagged - -  
H2 0.0663 2.723 108.9  
Standard3 4 A3 Flagged 0.00054 - -  
B3 0.0711 3.861 96.53  
C3 0.0706 3.738 93.46  
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D3 0.0718 4.035 100.9  
E3 0.0703 3.665 91.62  
F3 0.0708 3.787 94.68  
G3 0.0702 3.641 91.01 
 
H3 0.0743 4.671 116.8  
Standard4 7.55 A4 0.0881 0.00104 8.596 113.9  
B4 0.0867 8.167 108.2  
C4 0.0865 8.106 107.4  
D4 0.0836 7.241 95.91  
E4 0.0843 7.447 98.64  
F4 0.0842 7.418 98.25  
G4 0.0797 6.125 81.12  
H4 Flagged - -  
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MyAssays intra-assay precision results 
 
         
       
a 0.03263 
       
b 0.8646 
       
c 1376 
       
d 1.769 
       
MSE 0.01613 
       
R² 0.9653 
       
SS 1.548 
       
SYX 0.1297 
         
         
         
         
         
         
         
         
         
         
         
         
Calibrator Wells Conc. Raw SEM Backfit Recovery 
% 
  
Standard1 A1 0 0.0474 0.000366 5.6 - 
  
B1   0.0474   5.6 - 
  
C1   0.0466   5.248 - 
  
D1   0.0463   5.117 - 
  
E1   0.0461   5.029 - 
  
F1   0.0458   4.899 - 
  
G1   0.0456   4.812 - 
  
H1   0.0487   6.179 - 
  
Standard2 A2 3.75 0.0522 0.00055 7.779 207.5 
  
B2   0.0536   8.435 224.9 
  
C2   0.0505   6.995 186.5 
  
D2   0.051   7.224 192.7 
  
E2   0.0491   6.359 169.6 
  
F2   0.0499   6.721 179.2 
  
G2   0.0493   6.45 172 
  
H2   0.0497   6.631 176.8 
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Standard3 A3 7.55 0.0543 0.000828 8.765 116.1 
  
B3   0.059   11.03 146.2 
  
C3   0.0558   9.48 125.6 
  
D3   0.0603   11.68 154.7 
  
E3   0.0553   9.241 122.4 
  
F3   0.0541   8.671 114.8 
  
G3   0.0565   9.817 130 
  
H3   0.0589   10.99 145.5 
  
Standard4 A4 15 0.0653 0.000372 14.2 94.65 
  
B4   0.0653   14.2 94.65 
  
C4   0.0646   13.84 92.27 
  
D4   0.0633   13.18 87.86 
  
E4   0.0633   13.18 87.86 
  
F4   0.0635   13.28 88.54 
  
G4   0.0661   14.61 97.39 
  
H4   0.0647   13.89 92.61 
  
Standard5 A5 37.5 0.107 0.0047 38.02 101.4 
  
B5   0.105   36.3 96.81 
  
C5   0.101   34 90.68 
  
D5   0.101   33.88 90.36 
  
E5   0.139   58.4 155.7 
  
F5   0.1   33.7 89.88 
  
G5   0.0996   33.34 88.92 
  
H5   0.101   34.12 91 
  
Standard6 A6 75.5 0.203 0.00698 105.7 140 
  
B6   0.173   82.37 109.1 
  
C6   0.152   67.72 89.69 
  
D6   0.152   67.37 89.23 
  
E6   0.152   67.16 88.95 
  
F6   0.148   64.99 86.08 
  
G6   0.144   62.02 82.14 
  
H6   0.148   64.71 85.71 
  
Standard7 A7 375 0.373 0.00441 269 71.72 
  
B7   0.395   294.9 78.63 
  
C7   0.377   273.9 73.03 
  
D7   0.382   279.2 74.44 
  
E7   0.385   283.1 75.5 
  
F7   0.358   252.4 67.3 
  
G7   0.368   263.3 70.21 
  
H7   0.362   256 68.28 
  
Standard8 A8 755 0.711 0.013 822.5 108.9 
  
B8   0.732   871.5 115.4 
  
C8   0.72   842.5 111.6 
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D8   0.724   852.6 112.9 
  
E8   0.822   1114 147.5 
  
F8   0.714   828.3 109.7 
  
G8   0.737   883.7 117 
  
H8   0.761   945.2 125.2 
  
Standard9 A9 3750 1.2 0.0469 3126 83.37 
  
B9   1.43   6927 184.7 
  
C9   1.18   3011 80.28 
  
D9   1.51   10090 269 
  
E9   1.41   6496 173.2 
  
F9   1.18   2966 79.1 
  
G9   1.37   5651 150.7 
  
H9   1.2   3166 84.43 
  
Standard10 A10 7550 1.39 0.0528 6068 80.37 
  
B10   1.67   33720 446.6 
  
C10   1.31   4519 59.85 
  
D10   1.31   4545 60.2 
  
E10   1.32   4597 60.89 
  
F10   1.63   22910 303.4 
  
G10   1.34   4961 65.71 
  
H10   1.31   4550 60.26 
  
Standard11 A11 75500 1.59 0.0115 16610 22 
  
B11   1.57   14590 19.33 
  
C11   1.55   12630 16.73 
  
D11   1.52   10600 14.04 
  
E11   1.53   11750 15.57 
  
F11   1.49   9221 12.21 
  
G11   1.51   10500 13.91 
  
H11   1.52   11050 14.64 
  
Standard12 A12 375000 1.57 0.107 14570 3.884 
  
B12   1.9   > Curve - 
  
C12   1.86   > Curve -   
D12   2.47   > Curve - 
  
E12   1.51   10450 2.787 
  
F12   2.03   > Curve - 
  
G12   2.12   > Curve - 
  
H12   1.91   > Curve - 
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MyAssay inter-assay precision results 
 
         
       
a 0.06088 
       
b 1.042 
       
c 362.4 
       
d 1.362 
       
MSE 0.0007965 
       
R² 0.9966 
       
SS 0.01434 
       
SYX 0.032 
         
         
         
         
         
         
         
         
         
Calibrator Wells Conc. Raw SEM Backfit Recovery 
%   
Standard1 A1 0 0.0583 0.00181 < Curve - 
  
B1   0.0623   0.5203 - 
  
C1   0.0645   1.281 - 
  
Standard2 A2 7.55 0.0814 0.00095 6.86 90.86 
  
B2   0.0785   5.914 78.33 
  
C2   0.0786   5.946 78.76 
  
Standard3 A3 35 0.172 0.00196 37.2 106.3 
  
B3   0.176   38.71 110.6 
  
C3   0.17   36.36 103.9 
  
Standard4 A4 75.5 0.254 0.00864 67.77 89.76 
  
B4   0.27   74.06 98.09 
  
C4   0.284   79.88 105.8 
  
Standard5 A5 755 0.96 0.0272 784.7 103.9 
  
B5   0.898   638.1 84.51 
  
C5   0.99   872.7 115.6 
  
Standard6 A6 7550 1.25 0.0391 3389 44.89 
  
B6 1.3 6376 84.45 
  
C6 1.38 > Curve - 
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a 0.05874 
       
b 0.9774 
       
c 183.9 
       
d 1.43 
       
MSE 0.001721 
       
R² 0.9935 
       
SS 0.03097 
       
SYX 0.04704 
         
         
         
         
         
         
         
         
         
         
Calibrator Wells Conc. Raw SEM Backfit Recovery 
%   
Standard1 A1 0 0.0579 0.0007 < Curve - 
  
B1 0.0558 < Curve - 
  
C1 0.0579 < Curve - 
  
Standard2 A2 7.55 0.112 0.00142 6.872 91.03 
  
B2 0.114 7.19 95.23 
  
C2 0.109 6.515 86.29 
  
Standard3 A3 35 0.302 0.00215 38.32 109.5 
  
B3 0.309 39.66 113.3 
  
C3 0.303 38.48 109.9 
  
Standard4 A4 75.5 0.449 0.00982 71.7 94.96 
  
B4 0.43 66.73 88.39 
  
C4 0.464 75.59 100.1 
  
Standard5 A5 755 1.26 0.053 1372 181.7 
  
B5 1.14 692 91.65 
  
C5 1.08 555.5 73.58 
  
Standard6 A6 7550 1.35 0.0435 3133 41.5 
  
B6 1.35 3071 40.68 
  
C6 1.48 > Curve - 
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a 0.0468 
       
b 1.01 
       
c 902.8 
       
d 1.57 
       
MSE 0.003538 
       
R² 0.9862 
       
SS 0.1698 
       
SYX 0.06212 
         
         
         
         
         
         
         
         
         
         
         
Calibrator Wells Conc. Raw SEM Backfit Recovery 
%   
Standard1 A1 0 0.0474 0.000366 0.3871 - 
  
B1 0.0474 0.3871 - 
  
C1 0.0466 < Curve - 
  
D1 0.0463 < Curve - 
  
E1 0.0461 < Curve - 
  
F1 0.0458 < Curve - 
  
G1 0.0456 < Curve - 
  
H1 0.0487 1.208 - 
  
Standard2 A2 7.55 0.0543 0.000828 4.712 62.41 
  
B2 0.059 7.65 101.3 
  
C2 0.0558 5.65 74.83 
  
D2 0.0603 8.464 112.1 
  
E2 0.0553 5.337 70.69 
  
F2 0.0541 4.587 60.76 
  
G2 0.0565 6.087 80.62 
  
H2 0.0589 7.588 100.5 
  
Standard3 A3 35 0.107 0.0047 38.55 110.1 
  
B3 0.105 36.71 104.9 
  
C3 0.101 34.23 97.8 
  
D3 0.101 34.1 97.43 
  
E3 0.139 59.65 170.4 
  
F3 0.1 33.9 96.87 
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G3 0.0996 33.51 95.75 
  
H3 0.101 34.36 98.17 
  
Standard4 A4 75.5 0.203 0.00698 105.4 139.6 
  
B4 0.173 83.25 110.3 
  
C4 0.152 68.95 91.32 
  
D4 0.152 68.6 90.86 
  
E4 0.152 68.39 90.59 
  
F4 0.148 66.24 87.74 
  
G4 0.144 63.28 83.81 
  
H4 0.148 65.97 87.37 
  
Standard5 A5 755 0.711 0.013 699.9 92.7 
  
B5 0.732 739.3 97.92 
  
C5 0.72 716 94.83 
  
D5 0.724 724.1 95.91 
  
E5 0.822 935.1 123.9 
  
F5 0.714 704.5 93.32 
  
G5 0.737 749.1 99.22 
  
H5 0.761 798.7 105.8 
  
Standard6 A6 7550 1.39 0.0528 6706 88.83 
  
B6 1.67 > Curve - 
  
C6 1.31 4355 57.68 
  
D6 1.31 4389 58.14 
  
E6 1.32 4457 59.04 
  
F6 1.63 > Curve - 
  
G6 1.34 4953 65.61 
  
H6 1.31 4395 58.22 
  
        
 
      
a 0.06163 
      
b 1.036 
      
c 435.5 
      
d 1.279 
      
MSE 0.0009924 
      
R² 0.9949 
      
SS 0.01786 
      
SYX 0.03572 
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Calibrator Wells Conc. Raw SEM Backfit Recovery 
%  
Standard1 A1 0 0.0538 0.00491 < Curve -  
B1 0.0555 < Curve - 
 
C1 0.0693 3.288 - 
 
Standard2 A2 7.55 0.0785 0.00333 7.089 93.89 
 
B2 0.088 10.99 145.6 
 
C2 0.0776 6.718 88.98 
 
Standard3 A3 35 0.144 0.00145 34.68 99.09 
 
B3 0.149 36.82 105.2 
 
C3 0.148 36.16 103.3 
 
Standard4 A4 75.5 0.246 0.00773 82.29 109 
 
B4 0.224 71.3 94.43 
 
C4 0.221 70.22 93.01 
 
Standard5 A5 755 0.815 0.0379 696.5 92.25 
 
B5 0.789 638.3 84.54 
 
C5 0.914 987.4 130.8 
 
Standard6 A6 7550 1.15 0.0379 3413 45.21 
 
B6 1.22 8455 112 
 
C6 1.28 > Curve - 
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Recovery results and graphs 
 
 
MILK, diluted with milk matrix
 spiked ricin pg/ml average pg/ml calculated from equation
0 NaN NaN NaN 1.262
7.55 NaN NaN NaN 1.548
75.5 7.546679 10591.97 NaN 7.547 6.420
755 114.3751 89.32504 141.02294 114.908 115.867
7550 18258.46 5710.232 6841.8294 6276.031 6445.660
75500 46144.66 213585.6 507634.03 360609.806 339663.023
755000 NaN 44065.39 48180.579 46122.982 47687.504
7550000 29090.77 36316.94 53031.918 39479.873 39568.510
WINE, diluted with wine matrix
 spiked ricin pg/ml average pg/ml calculated from equation
0 NaN NaN NaN 1.770
7.55 NaN NaN NaN 1.328
75.5 NaN NaN 32.5421 32.5421 2.291
755 NaN NaN NaN 1.642
7550 NaN NaN NaN 2.145
75500 13.5720 53.7159 73.4959 63.6059 64.322
755000 25.8581 22.8660 10.5693 24.3620 24.774
7550000 2883.575 3988.179 4919.188 3930.314 3959.722
FLOUR, extraction with 2 % acetic acid
 spiked ricin pg/ml average pg/ml calculated from equation
0 NaN NaN NaN 1.737
7.55 NaN NaN NaN 1.673
75.5 NaN NaN NaN 5.261
755 NaN NaN NaN 2.208
7550 NaN NaN NaN 2.431
75500 13.37217 NaN NaN 13.3722 6.289
755000 18.34444 26.36104 24.811859 25.5865 26.048
7550000 610.1975 509.1494 519.50476 546.284 558.702
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MILK, diluted with 0.03 % BSA 0.1% TritonX in PBS
 spiked ricin pg/ml average pg/ml ricin c (pg/ml) calculated from equation
0 3.5384 2.6330 NaN 3.0857 30.8572 31.2
01:10 75.5 NaN NaN NaN 19.3
01:10 755 10.4548 11.6309 16.4019 12.829 128.2917 111.0
01:10 7550 74.9653 70.1782 319.0056 154.716 1547.1638 722.9
01:10 75500 1040.7190 394.6471 424.3185 619.895 6198.9489 4060.9
01:10 755000 NaN NaN 4666.5913 4666.591 46665.9133 9555.3
01:10 7550000 NaN NaN NaN 7340.3
1/100 755000 971.9256 1300.6739 675.4849 982.695 98269.481 91501.1
1/100 7550000 NaN NaN 7129.5733 7129.5733 712957.326 1122235.7
WINE, diluted with 0.03 % BSA 0.1% TritonX in PBS
 spiked ricin pg/ml average pg/ml ricin c (pg/ml) calculated from equation
0 NaN NaN NaN 33.4
01:10 75.5 1.0230 3.2322 0.6220 1.6258 16.2576 8.4
01:10 755 9.0401 17.0907 11.4236 12.518 125.1813 102.9
01:10 7550 77.7391 74.0635 97.5079 83.103 831.0350 756.1
01:10 75500 2458.6296 770.0737 520.4942 1249.733 12497.3251 6191.3
01:10 755000 3424.7704 NaN 1190.7872 2307.779 23077.7878 26862.3
01:10 7550000 NaN NaN NaN 17608.0
1/100 755000 2401.0550 673.4283 1837.8689 1637.451 163745.071 209962.3
1/100 7550000 NaN NaN NaN 248088.9
WINE pH 8
 spiked ricin pg/ml average pg/ml calculated from equation
0 NaN 3.8104 NaN 3.8104 2.1
75.5 NaN NaN 0.1775 0.1775 0.03
755 1.7124 28.6806 13.7224 14.705 14.5
7550 28.8750 0.6007 1.9297 10.468 1.3
755000 217.5300 182.9462 179.4888 193.322 180.1
7550000 1403.3124 5785.5560 3699.4693 3629.446 4693.9
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FLOUR, extraction with  PBS-tween
 spiked ricin pg/ml average pg/ml calculated from equation
0 17.9214 NaN NaN 17.9214 0.4
7.55 NaN NaN NaN 1.9
75.5 NaN 9.0290 NaN 9.0290 1.4
755 NaN NaN 7.9388 7.939 1.0
7550 32.7525 31.7010 27.9473 30.800 32.6
75500 331.9177 240.9892 244.1056 272.337 243.5
755000 NaN 1653.5475 1959.9018 1806.725 1802.0
7550000 NaN 5039.8073 NaN 5039.807 7147.3
